当前位置:首页 - 行情中心 - 信邦制药(002390) - 财务分析 - 现金流量表

信邦制药

(002390)

  

流通市值:74.61亿  总市值:75.23亿
流通股本:19.28亿   总股本:19.44亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,916,946,301.831,380,057,674.156,285,555,281.014,659,726,105.45
  收到其他与经营活动有关的现金91,226,791.4865,040,786.7103,414,416.11184,531,428.85
  经营活动现金流入小计3,008,173,093.311,445,098,460.856,388,969,697.124,844,257,534.3
  购买商品、接受劳务支付的现金2,134,493,536.851,032,022,830.774,287,605,550.343,238,306,826.56
  支付给职工以及为职工支付的现金377,438,379.22209,842,541.7739,764,377.72566,595,779.77
  支付的各项税费95,985,631.8147,420,555.96222,006,002.93168,544,427.59
  支付其他与经营活动有关的现金172,829,897.63100,792,467.83504,624,803.54440,964,224.6
  经营活动现金流出小计2,780,747,445.511,390,078,396.265,754,000,734.534,414,411,258.52
  经营活动产生的现金流量净额227,425,647.855,020,064.59634,968,962.59429,846,275.78
二、投资活动产生的现金流量:
  收回投资收到的现金10,000,000-3,099,714.532,546,481.79
  取得投资收益收到的现金304,964.14101,384.144,083,342.251,300,500.19
  处置固定资产、无形资产和其他长期资产收回的现金净额741,194.9105,5002,653,383.5185,920
  投资活动现金流入小计11,046,159.04206,884.149,836,440.293,932,901.98
  购建固定资产、无形资产和其他长期资产支付的现金55,902,231.3535,054,206.07124,867,551.1596,074,785.76
  投资活动现金流出小计55,902,231.3535,054,206.07124,867,551.1596,074,785.76
  投资活动产生的现金流量净额-44,856,072.31-34,847,321.93-115,031,110.86-92,141,883.78
三、筹资活动产生的现金流量:
  取得借款收到的现金358,000,000153,000,000895,100,000583,000,000
  收到其他与筹资活动有关的现金82,795,072.5682,795,072.5675,293,204.4675,293,204.46
  筹资活动现金流入小计440,795,072.56235,795,072.56970,393,204.46658,293,204.46
  偿还债务支付的现金409,300,000120,000,000900,100,000731,000,000
  分配股利、利润或偿付利息支付的现金141,295,651.9677,840,630.58226,418,939.66164,929,332.14
  其中:子公司支付给少数股东的股利、利润73,869,95073,255,00034,128,50034,128,500
  支付其他与筹资活动有关的现金48,511,212.3478,668,573.73161,780,925.21122,487,591.18
  筹资活动现金流出小计599,106,864.3276,509,204.311,288,299,864.871,018,416,923.32
  筹资活动产生的现金流量净额-158,311,791.74-40,714,131.75-317,906,660.41-360,123,718.86
四、汇率变动对现金及现金等价物的影响3,735.541,197.23-725.16607.07
五、现金及现金等价物净增加额24,261,519.29-20,540,191.86202,030,466.16-22,418,719.79
  加:期初现金及现金等价物余额932,720,240.84932,720,240.84730,689,774.68730,689,774.68
  期末现金及现金等价物余额956,981,760.13912,180,048.98932,720,240.84708,271,054.89
补充资料:
  净利润142,445,335.96-155,690,056.99-
  资产减值准备6,287,040.22-71,613,580.23-
  固定资产和投资性房地产折旧92,264,340.2-197,543,689.22-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧92,264,340.2-197,543,689.22-
  无形资产摊销7,410,658.84-14,709,069.22-
  长期待摊费用摊销6,805,008.7-16,891,536.98-
  处置固定资产、无形资产和其他长期资产的损失-95,696.33-2,291,981.97-
  固定资产报废损失832,085.64-1,108,572.31-
  财务费用12,446,340.67-26,447,386.46-
  投资损失-304,964.14--2,926,543.94-
  递延所得税-97,792.34--7,843,316.82-
  其中:递延所得税资产减少14,794.07--7,733,283.01-
    递延所得税负债增加-112,586.41--110,033.81-
  存货的减少102,722,036.05--63,636,295.45-
  经营性应收项目的减少57,252,761.75-334,130,512.54-
  经营性应付项目的增加-203,361,597.48--116,894,722.61-
  不涉及现金收支的投资和筹资活动金额其他项目--1,320,595.15-
  现金的期末余额956,981,760.13-932,720,240.84-
  减:现金的期初余额932,720,240.84-730,689,774.68-
  现金及现金等价物的净增加额24,261,519.29-202,030,466.16-
公告日期2025-08-302025-04-302025-04-152024-10-31
审计意见(境内)标准无保留意见
TOP↑